Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platina trial
2015-005811-34Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in maternal hypertension (HDP) and hypertension (HTN) comparing Labetalol with Nicardipine (2 arms). Primary endpoint: Composite adverse neonatal outcome. Started May 2018; status: completed.
02
Drugs
labetalolnicardipine
03
Conditions
maternal hypertension (HDP)hypertension (HTN)
Beyond the preview
Go deeper on 2015-005811-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005811-34.